Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

Rain ending this evening and winds shifting back to the north behind our latest cold front, and while dry for the weekend, expect a rather cool breeze with highs holding near 50. A quick weekend “cool ...